Search

Gigi Georgiana Huang

Examiner (ID: 12753)

Most Active Art Unit
1613
Art Unit(s)
1618, 1627, 1629, 1609, 1612, 1613, 1617, 1621
Total Applications
781
Issued Applications
217
Pending Applications
66
Abandoned Applications
506

Applications

Application numberTitle of the applicationFiling DateStatus
Array ( [id] => 5029001 [patent_doc_number] => 20070270448 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-11-22 [patent_title] => 'Methods of Using and Compositions Comprising a Jnk Inhibitor for the Treatment and Management of Asbestos-Related Diseases and Disorders' [patent_app_type] => utility [patent_app_number] => 10/578809 [patent_app_country] => US [patent_app_date] => 2004-11-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 20672 [patent_no_of_claims] => 29 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0270/20070270448.pdf [firstpage_image] =>[orig_patent_app_number] => 10578809 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/578809
Methods of Using and Compositions Comprising a Jnk Inhibitor for the Treatment and Management of Asbestos-Related Diseases and Disorders Nov 3, 2004 Abandoned
Array ( [id] => 5193553 [patent_doc_number] => 20070082037 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-04-12 [patent_title] => 'Transdermal preparations and method for relieving side effects in pergolide therapy' [patent_app_type] => utility [patent_app_number] => 10/577746 [patent_app_country] => US [patent_app_date] => 2004-10-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 6397 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0082/20070082037.pdf [firstpage_image] =>[orig_patent_app_number] => 10577746 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/577746
Transdermal preparations and method for relieving side effects in pergolide therapy Oct 28, 2004 Abandoned
Array ( [id] => 6971273 [patent_doc_number] => 20050036983 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-02-17 [patent_title] => 'In vivo use of water absorbent polymers' [patent_app_type] => utility [patent_app_number] => 10/949859 [patent_app_country] => US [patent_app_date] => 2004-09-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 5271 [patent_no_of_claims] => 25 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0036/20050036983.pdf [firstpage_image] =>[orig_patent_app_number] => 10949859 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/949859
In vivo use of water absorbent polymers Sep 23, 2004 Abandoned
Array ( [id] => 6971362 [patent_doc_number] => 20050037072 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-02-17 [patent_title] => 'Pharmaceutical compositions for rectal and vaginal administration' [patent_app_type] => utility [patent_app_number] => 10/946556 [patent_app_country] => US [patent_app_date] => 2004-09-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 2879 [patent_no_of_claims] => 25 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0037/20050037072.pdf [firstpage_image] =>[orig_patent_app_number] => 10946556 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/946556
Pharmaceutical compositions for rectal and vaginal administration Sep 20, 2004 Abandoned
Array ( [id] => 5183586 [patent_doc_number] => 20070054940 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-03-08 [patent_title] => 'Remedy for down\'s syndrome' [patent_app_type] => utility [patent_app_number] => 10/572090 [patent_app_country] => US [patent_app_date] => 2004-09-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 6737 [patent_no_of_claims] => 26 [patent_no_of_ind_claims] => 11 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0054/20070054940.pdf [firstpage_image] =>[orig_patent_app_number] => 10572090 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/572090
Remedy for down's syndrome Sep 16, 2004 Abandoned
Array ( [id] => 5904659 [patent_doc_number] => 20060047005 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-03-02 [patent_title] => 'Compositions containing N,N,N\',N\'-tetrakis(hydroxyalkyl)diamine-or N,N,N\',N\'-tetrakis(hydroxyalkoxy)diamine-based buffers' [patent_app_type] => utility [patent_app_number] => 10/926504 [patent_app_country] => US [patent_app_date] => 2004-08-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 6485 [patent_no_of_claims] => 92 [patent_no_of_ind_claims] => 10 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0047/20060047005.pdf [firstpage_image] =>[orig_patent_app_number] => 10926504 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/926504
Compositions containing N,N,N',N'-tetrakis(hydroxyalkyl)diamine-or N,N,N',N'-tetrakis(hydroxyalkoxy)diamine-based buffers Aug 25, 2004 Abandoned
Array ( [id] => 5904462 [patent_doc_number] => 20060046958 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-03-02 [patent_title] => 'Compositions and methods comprising prostaglandin related compounds and trefoil factor family peptides for the treatment of glaucoma with reduced hyperemia' [patent_app_type] => utility [patent_app_number] => 10/521367 [patent_app_country] => US [patent_app_date] => 2004-08-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 6263 [patent_no_of_claims] => 28 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0046/20060046958.pdf [firstpage_image] =>[orig_patent_app_number] => 10521367 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/521367
Compositions and methods comprising prostaglandin related compounds and trefoil factor family peptides for the treatment of glaucoma with reduced hyperemia Aug 24, 2004 Issued
Array ( [id] => 5687858 [patent_doc_number] => 20060286173 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-12-21 [patent_title] => 'Drug delivery system for sub-tenon s capsule adminstration of fine grains' [patent_app_type] => utility [patent_app_number] => 10/568892 [patent_app_country] => US [patent_app_date] => 2004-08-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 4504 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0286/20060286173.pdf [firstpage_image] =>[orig_patent_app_number] => 10568892 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/568892
Drug delivery system for sub-tenon s capsule adminstration of fine grains Aug 19, 2004 Abandoned
Array ( [id] => 5835389 [patent_doc_number] => 20060247220 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-11-02 [patent_title] => 'Preventing the crystallization of cholesterol using oxysterols' [patent_app_type] => utility [patent_app_number] => 10/568676 [patent_app_country] => US [patent_app_date] => 2004-08-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 1658 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0247/20060247220.pdf [firstpage_image] =>[orig_patent_app_number] => 10568676 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/568676
Preventing the crystallization of cholesterol using oxysterols Aug 18, 2004 Abandoned
Array ( [id] => 5590520 [patent_doc_number] => 20060039971 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-02-23 [patent_title] => 'Effervescent composition including alternative hormone replacement therapy agent' [patent_app_type] => utility [patent_app_number] => 10/921698 [patent_app_country] => US [patent_app_date] => 2004-08-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 4066 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0039/20060039971.pdf [firstpage_image] =>[orig_patent_app_number] => 10921698 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/921698
Effervescent composition including alternative hormone replacement therapy agent Aug 18, 2004 Abandoned
Array ( [id] => 7024965 [patent_doc_number] => 20050019359 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-01-27 [patent_title] => 'Cosmetic films' [patent_app_type] => utility [patent_app_number] => 10/919736 [patent_app_country] => US [patent_app_date] => 2004-08-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 6505 [patent_no_of_claims] => 23 [patent_no_of_ind_claims] => 14 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0019/20050019359.pdf [firstpage_image] =>[orig_patent_app_number] => 10919736 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/919736
Cosmetic films Aug 16, 2004 Abandoned
Array ( [id] => 7145650 [patent_doc_number] => 20050119262 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-06-02 [patent_title] => 'Method for preventing or treating an optic neuropathy with a cox-2 inhibitor and an intraocular pressure reducing agent' [patent_app_type] => utility [patent_app_number] => 10/919835 [patent_app_country] => US [patent_app_date] => 2004-08-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 16149 [patent_no_of_claims] => 47 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0119/20050119262.pdf [firstpage_image] =>[orig_patent_app_number] => 10919835 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/919835
Method for preventing or treating an optic neuropathy with a cox-2 inhibitor and an intraocular pressure reducing agent Aug 16, 2004 Abandoned
Array ( [id] => 7088585 [patent_doc_number] => 20050008697 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-01-13 [patent_title] => 'Oral solid solution formulation of a poorly water-soluble active substance' [patent_app_type] => utility [patent_app_number] => 10/915560 [patent_app_country] => US [patent_app_date] => 2004-08-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 4203 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0008/20050008697.pdf [firstpage_image] =>[orig_patent_app_number] => 10915560 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/915560
Oral solid solution formulation of a poorly water-soluble active substance Aug 10, 2004 Abandoned
Array ( [id] => 7033188 [patent_doc_number] => 20050031697 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-02-10 [patent_title] => 'Compositions for delivery of therapeutics into the eyes and methods for making and using same' [patent_app_type] => utility [patent_app_number] => 10/911966 [patent_app_country] => US [patent_app_date] => 2004-08-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 12937 [patent_no_of_claims] => 40 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0031/20050031697.pdf [firstpage_image] =>[orig_patent_app_number] => 10911966 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/911966
Compositions for delivery of therapeutics into the eyes and methods for making and using same Aug 4, 2004 Issued
Array ( [id] => 5873163 [patent_doc_number] => 20060165793 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-07-27 [patent_title] => 'Pharmaceutical preparation to be dispersed before administration' [patent_app_type] => utility [patent_app_number] => 10/564402 [patent_app_country] => US [patent_app_date] => 2004-08-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 5177 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0165/20060165793.pdf [firstpage_image] =>[orig_patent_app_number] => 10564402 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/564402
Pharmaceutical preparation to be dispersed before administration Aug 3, 2004 Abandoned
Array ( [id] => 7088591 [patent_doc_number] => 20050008703 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-01-13 [patent_title] => 'Medical formulation containing a muscarinic agonist' [patent_app_type] => utility [patent_app_number] => 10/909772 [patent_app_country] => US [patent_app_date] => 2004-08-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 2936 [patent_no_of_claims] => 23 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0008/20050008703.pdf [firstpage_image] =>[orig_patent_app_number] => 10909772 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/909772
Medical formulation containing a muscarinic agonist Aug 1, 2004 Abandoned
Array ( [id] => 7088586 [patent_doc_number] => 20050008698 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-01-13 [patent_title] => 'Base material for dry direct tableting comprising low-substituted hydroxypropyl cellulose' [patent_app_type] => utility [patent_app_number] => 10/909236 [patent_app_country] => US [patent_app_date] => 2004-07-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3663 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0008/20050008698.pdf [firstpage_image] =>[orig_patent_app_number] => 10909236 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/909236
Base material for dry direct tableting comprising low-substituted hydroxypropyl cellulose Jul 29, 2004 Abandoned
Array ( [id] => 7010494 [patent_doc_number] => 20050064210 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-03-24 [patent_title] => 'Coating for use with medical devices and method of making same' [patent_app_type] => utility [patent_app_number] => 10/900016 [patent_app_country] => US [patent_app_date] => 2004-07-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3370 [patent_no_of_claims] => 45 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0064/20050064210.pdf [firstpage_image] =>[orig_patent_app_number] => 10900016 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/900016
Coating for use with medical devices and method of making same Jul 25, 2004 Abandoned
Array ( [id] => 5769495 [patent_doc_number] => 20060020044 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-01-26 [patent_title] => 'Methods and compositions for treating or preventing macular-degeneration related disorders' [patent_app_type] => utility [patent_app_number] => 10/898893 [patent_app_country] => US [patent_app_date] => 2004-07-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 6817 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0020/20060020044.pdf [firstpage_image] =>[orig_patent_app_number] => 10898893 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/898893
Methods and compositions for treating or preventing macular-degeneration related disorders Jul 25, 2004 Abandoned
Array ( [id] => 7435419 [patent_doc_number] => 20040266792 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-12-30 [patent_title] => 'Hydroxyrisperidone compositions and methods' [patent_app_type] => new [patent_app_number] => 10/891236 [patent_app_country] => US [patent_app_date] => 2004-07-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3228 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0266/20040266792.pdf [firstpage_image] =>[orig_patent_app_number] => 10891236 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/891236
Hydroxyrisperidone compositions and methods Jul 12, 2004 Abandoned
Menu